The stent hadn’t helped after all; the impacted kidney had, in fact, been irreversibly damaged and was now functioning at a paltry 20%. Why? The cancer was back, and worse.

The global ureteral stent market is experiencing significant growth, with the market projected to rise from USD 385.9 million in 2022 to a promising USD 616.8 million by 2032, advancing at a steady ...